WinstonWınston
Strategic Global Investments logo

Strategic Global Investments

STBV
20
Medical - Specialties · Healthcare
Price
$0.00
+0.00 (+0.00%)
Market Cap
$471
Winston Score
20
Winston is worried
Weak fundamentals across most pillars.
Based on the IPO prospectus (annual filing). This score will refine automatically once the company reports its first quarters.

Share count rising — dilution

+63433.9% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 3K (2010) → 2.0M (2014)

Strategic Global Investments, Inc. is a small healthcare company that focuses on medical specialty products and services. It operates in the medical specialties segment of the healthcare industry, targeting niche markets within the broader health sector. The company is very small, with a market cap that rounds to essentially zero, which places it in the micro-cap or nano-cap category.

The company generates revenue through product sales and services related to its medical specialty focus, reflected in a gross margin of around 44%. However, its operating margin is deeply negative, meaning it spends far more running the business than it earns — a common challenge for early-stage or restructuring companies. It appears to operate on a limited geographic scale. The biggest risk this company faces is financial sustainability: with a return on invested capital of nearly negative 49% and severe operating losses, it must either grow revenue significantly or cut costs sharply to survive long-term.

Winston Score History

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

R&D Spend

$0/ year

0.0% of revenue

Below sector average (18%)

Research and development spending

Insider Activity

100.0%ownership

Flat

Insiders holding steady — not selling despite ability to

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
43.5%
no trend
Healthy — 43.5% gross margin
Operating Margin
-3682.6%
no trend
Losing money on operations — -3682.6%
ROCE
-48.9%
no trend
Weak — -48.9% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
+260.4%
no trend
Fast-growing sales (260.4% YoY)
EPS YoY
N/A
no trend
Data not available
EPS Consistency
N/A
no trend
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
N/A
no trend
Data not available
FCF Margin
-4259.9%
no trend
Burning cash (-4259.9%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
0.12
no trend
Conservative — low debt load (0.12)
Interest Cover
N/A
no trend
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
N/M
no trend
Negative earnings — P/E not meaningful
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial